CDH1 and penile cancer: Similar results were previously found in studies of oral, oropharyngeal, and penile cancers.14,16,47 Although we found no relationship between E-cadherin and patient survival, we can deduce that the patients with low E-cadherin expression typically exhibit high-grade tumors, which have a higher likelihood of recurrence, and this may impact the survival.